Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history

被引：0
|
作者：
Golebiewska, Anna [1 ]
Oudin, Anais [1 ]
Baus, Virginie [1 ]
Hau, Ann-Christin [1 ]
Klein, Eliane [1 ]
Steino, Anne [2 ]
Bacha, Jeffrey A. [3 ]
Niclou, Simone P. [1 ]
Brown, Dennis M. [4 ]
机构：
[1] Luxembourg Inst Hlth, Luxembourg, Luxembourg
[2] DelMar Pharmaceut Inc, Vancouver, BC, Canada
[3] ORP Canada Ltd, Vancouver, BC, Canada
[4] DelMar Pharmaceut Inc, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5231
引用
收藏
页数：2
相关论文
共 3 条
  • [1] Dianhydrogalactitol (VAL-083) offers potential therapeutic alternatives in the treatment of pediatric brain tumors
    Bacha, Jeffrey A.
    Fotovati, Abbas
    Hu, Kaiji
    Steino, Anne
    Kanekal, Sarath
    Brown, Dennis M.
    CANCER RESEARCH, 2016, 76
  • [2] Dianhydrogalactitol (VAL-083) for the treatment of glioblastoma multiforme (GBM): Impact of glucose transporters for crossing the blood brain barrier (BBB)
    Langlands, John M.
    Kanekal, Sarath
    Steino, Anne
    Mendez, Armando
    Karman, Zoltan
    Toth, Beata Martonne
    Heredi-Szabo, Krisztina
    Brown, Dennis
    CANCER RESEARCH, 2022, 82 (12)
  • [3] DIANHYDROGALACTITOL (VAL-083) CAUSES BIFUNCTIONAL ALKYLATION LEADING TO IRREPARABLE DNA DOUBLE-STRAND BREAKS, S/G2 PHASE CELL-CYCLE ARREST AND TUMOR CELL DEATH IN AN MGMT INDEPENDENT MANNER OFFERING A UNIQUE TREATMENT PARADIGM FOR GBM
    Zhai, B.
    Steino, A.
    Bacha, J. A.
    Brown, D. M.
    Daugaard, M.
    NEURO-ONCOLOGY, 2016, 18 : 52 - 52
1